The cost-effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030.
Xiao Y, Hellard ME, Thompson AJ, Seaman C, Howell J, Scott N
Hepatitis BExploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.
Wallace J, Richmond J, Howell J, Hajarizadeh B, Power J, Treloar C, Revill PA, Cowie B, Wang S, Stoové M, Pedrana A, Hellard M
Hepatitis BLenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study.
Patwala K, Prince DS, Celermajer Y, Alam W, Paul E, Strasser SI, McCaughan GW, Gow P, Sood S, Murphy E, Roberts S, Freeman E, Stratton E, Davison SA, Levy MT, Clark-Dickson M, Nguyen V, Bell S, Nicoll A, Bloom A, Lee AU, Ryan M, Howell J, Valaydon Z, Mack A, Liu K, Dev A